Adderall Capsule, Extended Release
Product Images NDC 54092-389

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Adderall (NDC 54092-389). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adderall Xr 01

A line graph comparing the mean plasma concentrations (ng/mL) of dextroamphetamine and levoamphetamine over 24 hours for Adderall XR 20 mg once daily and Adderall 10 mg twice daily. The graph shows four curves representing dextroamphetamine and levoamphetamine concentrations for each dosing regimen, plotted against time in hours on the x-axis and concentration on the y-axis.*

FDA Label Image

Principal Display Panel (5 mg Capsule Bottle Label)

Label for Adderall XR 5 mg extended-release capsules by Takeda Pharmaceuticals America, Inc. The label notes it contains mixed salts of a single-entity amphetamine product and is for oral use. The package size is 100 capsules, with Rx only designation. The label includes storage instructions and a barcode.*

FDA Label Image

Principal Display Panel (10 mg Capsule Bottle Label)

Label of Adderall XR 10 mg extended-release capsules by Takeda Pharmaceuticals America, Inc. The label states it contains mixed salts of a single-entity amphetamine product in a 100-capsule quantity. It includes storage instructions, active ingredients, and the NDC barcode.*

FDA Label Image

Principal Display Panel (15 mg Capsule Bottle Label)

Label for Adderall XR 15 mg extended-release capsules by Takeda Pharmaceuticals America, Inc. It states the product is a mixed salts amphetamine with 100 capsules in the package for prescription use only. The label includes dosage information and storage instructions.*

FDA Label Image

Principal Display Panel (20 mg Capsule Bottle Label)

Label of Adderall XR 20 mg extended-release capsules by Takeda Pharmaceuticals America, Inc. The label states it contains 100 capsules of mixed salts of a single-entity amphetamine product, for oral use, prescription only. Storage instructions and ingredient details are also visible alongside the Takeda logo and barcode.*

FDA Label Image

Principal Display Panel (25 mg Capsule Bottle Label)

Adderall XR 25 mg extended-release capsules label by Takeda Pharmaceuticals America, Inc. The label describes the product as mixed salts of a single-entity amphetamine extended-release capsules. It indicates a package containing 100 capsules, with the strength prominently displayed as 25 mg. The label also includes storage instructions, prescription status (Rx only), and a barcode.*

FDA Label Image

Principal Display Panel (30 mg Capsule Bottle Label)

Label for Adderall XR 30 mg extended-release capsules, a mixed salts amphetamine product. The label indicates a package of 100 capsules, prescription use only, distributed by Takeda Pharmaceuticals America, Inc. Storage instructions and ingredient details are provided in small print on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.